Hemato Oncology Testing Market Strengthens Hematologic Cancer Detection
Market insights predict the global hemato-oncology testing industry will increase from USD 4 billion in 2025 to USD 12.88 billion by 2035, achieving a CAGR of 12.4%. In 2023, service offerings led the market with a 58% share. Leukemia remained the top focus, making up 40% of the market. PCR technology dominated testing methods with a 45% share, valued for its high accuracy and efficiency.
Last Updated : 13 January 2026Category: DiagnosticsInsight Code: 5123Format: PDF / PPT / Excel
Regulatory Framework for Leading Countries/Regions
Supply Demand Analysis
Production & Consumption Statistics
Export Import Statistics
Price Trend Analysis
Global Hemato Oncology Testing Market Assessment
Overview
Global Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Offerings (2021 – 2033)
Services
Assay Kits
Global Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
Leukemia
Acute Myeloid Leukemia
Acute Lymphocytic Leukemia
Other Leukemia
Lymphoma
Non-Hodgkin Lymphoma
Hodgkin Lymphoma
Other Cancers
Global Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
Next-Generation Sequencing (NGS)
Cytogenetics (Karyotyping, FISH)
Other Technologies
Global Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
Hospitals
Academic & Research Institutes
Others
Global Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
North America Hemato Oncology Testing Market Assessment
Overview
North America Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Offerings (2021 – 2033)
Services
Assay Kits
North America Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
Leukemia
Acute Myeloid Leukemia
Acute Lymphocytic Leukemia
Other Leukemia
Lymphoma
Non-Hodgkin Lymphoma
Hodgkin Lymphoma
Other Cancers
North America Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
Next-Generation Sequencing (NGS)
Cytogenetics (Karyotyping, FISH)
Other Technologies
North America Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
Hospitals
Academic & Research Institutes
Others
Europe Hemato Oncology Testing Market Assessment
Overview
Europe Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Offerings (2021 – 2033)
Services
Assay Kits
Europe Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
Leukemia
Acute Myeloid Leukemia
Acute Lymphocytic Leukemia
Other Leukemia
Lymphoma
Non-Hodgkin Lymphoma
Hodgkin Lymphoma
Other Cancers
Europe Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
Next-Generation Sequencing (NGS)
Cytogenetics (Karyotyping, FISH)
Other Technologies
Europe Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
Hospitals
Academic & Research Institutes
Others
Asia Pacific Hemato Oncology Testing Market Assessment
Overview
Asia Pacific Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Offerings (2021 – 2033)
Services
Assay Kits
Asia Pacific Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
Leukemia
Acute Myeloid Leukemia
Acute Lymphocytic Leukemia
Other Leukemia
Lymphoma
Non-Hodgkin Lymphoma
Hodgkin Lymphoma
Other Cancers
Asia Pacific Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
Next-Generation Sequencing (NGS)
Cytogenetics (Karyotyping, FISH)
Other Technologies
Asia Pacific Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
Hospitals
Academic & Research Institutes
Others
Latin America Hemato Oncology Testing Market Assessment
Overview
Latin America Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Offerings (2021 – 2033)
Services
Assay Kits
Latin America Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
Leukemia
Acute Myeloid Leukemia
Acute Lymphocytic Leukemia
Other Leukemia
Lymphoma
Non-Hodgkin Lymphoma
Hodgkin Lymphoma
Other Cancers
Latin America Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
Next-Generation Sequencing (NGS)
Cytogenetics (Karyotyping, FISH)
Other Technologies
Latin America Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
Hospitals
Academic & Research Institutes
Others
Middle East and Africa Hemato Oncology Testing Market Assessment
Overview
Middle East and Africa Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Offerings (2021 – 2033)
Services
Assay Kits
Middle East and Africa Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
Leukemia
Acute Myeloid Leukemia
Acute Lymphocytic Leukemia
Other Leukemia
Lymphoma
Non-Hodgkin Lymphoma
Hodgkin Lymphoma
Other Cancers
Middle East and Africa Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
Next-Generation Sequencing (NGS)
Cytogenetics (Karyotyping, FISH)
Other Technologies
Middle East and Africa Hemato Oncology Testing Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
Hospitals
Academic & Research Institutes
Others
Company Profiles
F. Hoffmann-La Roche Ltd.
Company Overview
Geographic Footprints
Financial Performance
Product Portfolio
SWOT Analysis
R&D Efforts
Recent Developments & Strategic Collaborations
Product Launch/M&A/Technical Collaboration
Qiagen N.V.
Abbott
EntroGen, Inc.
Illumina Inc.
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories
Sysmex Corporation
Danaher Corporation
Beckman Coulter, Inc.
Conclusion & Recommendations
FAQ's
Answer : The hemato-oncology testing market is expected to expand from USD 4 billion in 2025 to USD 12.88 billion by 2035, registering a strong CAGR of 12.4%
Answer : North America dominated the market in 2025, while Asia-Pacific is anticipated to be the fastest-growing region due to rising cancer incidence and expanding healthcare infrastructure.
Answer : Leading players such as Roche, Qiagen, Abbott, Illumina, Thermo Fisher Scientific, Danaher, and Bio-Rad Laboratories are driving innovation and market expansion.
Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare
market research. As a content reviewer, Aditi ensures the quality and accuracy of all market
insights and data presented by the research team.
We use cookies that are necessary to make our site work. We may also use additional cookies to analyze,
improve, and personalize our content and your digital experience.
You can manage your cookie preferences using the
Privacy Policy
For more information, see our
Terms and Conditions
.
Cookie Preference Center
We use cookies which are necessary to make our site work.
We may also use additional cookies to analyze, improve and personalize
our content and your digital experience.
For more information see our
Cookie Policy and
You may choose not to allow some types of cookies.
Blocking some cookies may impact your experience of the site.
+1 804-441-9344
Download Sample
USA : +1 8044 419344
